HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Joern Aldag$75.4M
Market Cap • 17/04/20242017
(há 7 anos)
2019
(5 years ago)
NASDAQ
Listagem
New York
Sede • New York178
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
HOOKSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.